This is a huge cut of employees, beyond what their core objective of the company is all about. If we see an external audit being conducted, then they are selling. The employee cut makes sense, admin people are going for sure along with most of the company. Bare bones prior to an acquisition is my view point. I was acquired twice in my career, employee cuts, dumping losing assets, not signing new leases, and then I was showing a Price Waterhouse guru all my regional retail store locations. We were bought within a few months into a joint partnership selling off 51% to the new owner, and keeping 49%.
About time......if it goes private we lose value in PPS, the buyer only wants the good stuff, minimal staff, and pipeline. Mark this post, ARENA is going on the block in some manner before year end.
I agree with you on that outcome....Wall Street is not stupid about ARNA's future. One advantage, it will cost less to produce Bel XR.
I am not sure if there is any planned marketing program to push Bel XR that might make a difference. Existing Scripts will most likely switch over, but we need new scripts from new patients. Will the price for once a day dosage result in the same incoming revenue?
Over the past 7 years, when the exec's are quite with not much to say, it's usually been an omen of pending bad news in the near future. They have rarely pumped ARNA, and the forward guidance is non-existent for the last 2 years plus.
70 thumbs down, 12 thumbs up ! 85% thinks you are a day dreaming fool who has no clue what a good investment looks like. You will be in your grave by the time they make a profit, or get any new drugs on the market actually making some revenue.
He is just reporting the facts......dilution so many times over their history goin back years.
Sentiment: Strong Sell
You folks are really stupid.......The weight loss sector is a BUSTED idea. The doctors are not embracing an expensive pill....ENUF SAID! Belviq XR will not make a difference to ARNA's bottom line. My hope the PR news release is really pumped up to raise the PPS via market makers who are in on the action. Be ready to exit if you want out as the share price increases. BELVIQ is a failed product.......just ask EASAI.
Are you kidding me..........1000's want to sell, but not at a total loss. If $2.50 pps comes back on the radar screen, you will see a mass exit of retail cashing out. I will be at the front of the SELL line.
A basket of crooks living large on our dime. If they run the share price up to unload more dilutive shares, I am out for good. It's doubtful they will get any FDA approval before going totally broke. Not certain if any buyout actually might happen within a year........who would want this burden on their balance sheet. It would have to go real cheap. Sadly, the new management has not given us any hope of a big pharma buyout, as they line their pockets.
Wall Street knows one detail about patients......they don't produce a dime of revenue tomorrow, and they are very expensive to defend in court with a successful judgement of $$$millions coming your way. Like a mineral right's lease..... it's only worth the future value that you can actually extract and sell minerals from the lease....same thing goes for a drug patient. The value is very overstated generally from the company with the patient when they start projecting potential value of future drug revenue when they still remain years away from a dime of revenue from said patient. It makes a good PR statement, but you can't find it on the balance sheet.
Good luck on your foolish, risky investment. Over 20 years their success has produced marginal success of any drug discovery that could have made ARENA profitable. They are operating in survival mode.....that says it all about your likely investment outcome. Your money, your risk.......GLTA.
And in what year will it begin producing profits & or revenue for ARENA? 3 or 4 years out, and only on FDA approval. More than 20 years of no successful drug to support this company.....it's a scam of high paid exec's who's dream is to discover the next miracle drug on our dime. They have made a career out of it for the past 2 decades. Enuf said.
You Bozo's who cheer this stock must be blind, or can't afford to take the loss. Four years ago it traded above $10 pps, and then it went below $6, below $4, now it trades below $1.90 pps. Each time a result of poor returns on Belviq, and additional dilution. It's past time to sell this company as the share holders are about to get screwed again to raise needed capital. It's a very, very, real long shot to ever get profitable on drugs in the pipeline even with a partner within the next three years. Thanks Jack for your poor judgement along the way.....your grand plan was a failure of hope, if's, and the maybe outcome of events.
Once a true long, now a angry shareholder.....I am selling out but made money during the long downtrend thanks to owning many early shares purchased in the $1.65 range. They are operating in survival mode for the immediate future and beyond.
Sell the whole company. CEO said they want to sell underperforming assets? In my view on recent quarters, the whole company underperforming. Sell....Sell....Sell so us longs can make a buck on our holdings. Other interest looking to buy their assets can certainly make an offer for the whole lot. Let's see what happens, some assets may have an offer pending an announcement very soon.